Chad Hamilton to Endometrial Neoplasms
This is a "connection" page, showing publications Chad Hamilton has written about Endometrial Neoplasms.
Connection Strength
4.021
-
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations. Gynecol Oncol. 2021 03; 160(3):817-826.
Score: 0.643
-
Endometrial cancer: A society of gynecologic oncology evidence-based review and recommendations, part II. Gynecol Oncol. 2021 03; 160(3):827-834.
Score: 0.641
-
Acute postoperative thrombotic thrombocytopenic purpura following hysterectomy and lymphadenectomy for endometrial cancer. Gynecol Oncol. 2007 Aug; 106(2):423-6.
Score: 0.249
-
Uterine papillary serous and clear cell carcinomas predict for poorer survival compared to grade 3 endometrioid corpus cancers. Br J Cancer. 2006 Mar 13; 94(5):642-6.
Score: 0.229
-
Impact of adjuvant therapy on survival of patients with early-stage uterine papillary serous carcinoma. Int J Radiat Oncol Biol Phys. 2005 Nov 01; 63(3):839-44.
Score: 0.224
-
Conditional estimates for uterine serous cancer: Tools for survivorship counseling and planning. Gynecol Oncol. 2022 07; 166(1):90-99.
Score: 0.176
-
Jupiter microtubule-associated homolog 1 (JPT1): A predictive and pharmacodynamic biomarker of metformin response in endometrial cancers. Cancer Med. 2020 02; 9(3):1092-1103.
Score: 0.149
-
Final analysis of a phase I/IIa trial of the folate-binding protein-derived E39 peptide vaccine to prevent recurrence in ovarian and endometrial cancer patients. Cancer Med. 2019 08; 8(10):4678-4687.
Score: 0.144
-
Biomarker panel for early detection of endometrial cancer in the Prostate, Lung, Colorectal, and Ovarian cancer screening trial. Am J Obstet Gynecol. 2019 11; 221(5):472.e1-472.e10.
Score: 0.144
-
Racial disparities in molecular subtypes of endometrial cancer. Gynecol Oncol. 2018 04; 149(1):106-116.
Score: 0.132
-
Surgical outcomes among elderly women with endometrial cancer treated by laparoscopic hysterectomy: a NRG/Gynecologic Oncology Group study. Am J Obstet Gynecol. 2018 01; 218(1):109.e1-109.e11.
Score: 0.128
-
Impact of age at diagnosis on racial disparities in endometrial cancer patients. Gynecol Oncol. 2018 04; 149(1):12-21.
Score: 0.126
-
Race-specific molecular alterations correlate with differential outcomes for black and white endometrioid endometrial cancer patients. Cancer. 2017 Oct 15; 123(20):4004-4012.
Score: 0.125
-
Interim analysis of a phase I/IIa trial assessing E39+GM-CSF, a folate binding protein vaccine, to prevent recurrence in ovarian and endometrial cancer patients. Oncotarget. 2017 Feb 28; 8(9):15912-15923.
Score: 0.123
-
Progesterone potentiates the growth inhibitory effects of calcitriol in endometrial cancer via suppression of CYP24A1. Oncotarget. 2016 Nov 22; 7(47):77576-77590.
Score: 0.120
-
Nestin suppression attenuates invasive potential of endometrial cancer cells by downregulating TGF-? signaling pathway. Oncotarget. 2016 Oct 25; 7(43):69733-69748.
Score: 0.120
-
MicroRNAs in endometrial cancers from black and white patients. Am J Obstet Gynecol. 2015 Feb; 212(2):191.e1-10.
Score: 0.103
-
Progesterone inhibits endometrial cancer invasiveness by inhibiting the TGF? pathway. Cancer Prev Res (Phila). 2014 Oct; 7(10):1045-55.
Score: 0.102
-
Progesterone enhances calcitriol antitumor activity by upregulating vitamin D receptor expression and promoting apoptosis in endometrial cancer cells. Cancer Prev Res (Phila). 2013 Jul; 6(7):731-43.
Score: 0.094
-
Transcript expression in endometrial cancers from Black and White patients. Gynecol Oncol. 2013 Jul; 130(1):169-73.
Score: 0.094
-
Standardization of a sample preparation and analytical workflow for proteomics of archival endometrial cancer tissue. J Proteome Res. 2011 Nov 04; 10(11):5264-71.
Score: 0.084
-
Racial disparities in recurrence among patients with early-stage endometrial cancer: is recurrence increased in black patients who receive estrogen replacement therapy? Cancer. 2008 Sep 15; 113(6):1431-7.
Score: 0.068